Thursday, August 20, 2020

Dementia Friendly Communities Virtual Conference

For some months now, I've been working with people from Harborview Medical Center in Seattle on a conference about creating dementia-friendly communities.  Here's the conference web site.  It's intended to be an opportunity for leaders to come together and explore ways that communities can be more hospitable to people with dementia.  For example, what should first responders consider when they are called to a situation involving someone elderly and erratic?  How have grocery stores prepared their workers for someone unable to properly navigate a simple purchase?  How do we prepare our communities for these scenarios as our elderly population grows?

As with all conferences in The Age of Covid, it will be virtual -- September 29 and 30.  Cost is $15 for community members and $40 for professionals.  (We're still trying to refine how to distinguish the two...)  As initially planned, it would have been held in a conference center in Tukwila, and it would have been pretty Seattle-centric.  But now anyone can attend from anywhere in the country!  

The conference will feature Meredith Hanley, project director for Dementia Friendly America

On day two (September 30) at 9:15 Pacific Time, I will participate in a panel discussion with two thought leaders.  So if you're interested, you can see me then.  (You will, of course, need to register.)

We have been working very hard to make this an interesting and beneficial event, and I am quite excited about it. We designed it to benefit the following people: 

  • Aging and senior services 
  • Arts and culture 
  • Chambers of commerce 
  • City government 
  • Community centers 
  • Cultural associations 
  • Faith communities 
  • Libraries 
  • Neighborhood groups 
  • Parks and recreation 
  • Service clubs 
  • Social or health care services

As it turns out, I'm also working on planning for another conference with the Alzheimer's Association in November.  So stay tuned for that one.

No comments:

Post a Comment

Welcome Kisunla

We reported previously that the FDA's advisory panel had recommended approval of the monoclonal antibody treatment donanemab.  This foll...